Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,594
Closed -$124K 559
2020
Q2
$124K Buy
+2,594
New +$50.2K 0.09% 276
2019
Q4
$535K Buy
+13,651
New +$502K 0.28% 245
2019
Q3
Sell
-10,143
Closed -$355K 490
2019
Q2
$355K Buy
10,143
+3,088
+44% +$107K 0.29% 91
2019
Q1
$242K Buy
+7,055
New +$259K 0.21% 326
2018
Q4
Sell
-3,504
Closed -$160K 533
2018
Q3
$160K Buy
3,504
+240
+7% +$12.1K 0.26% 310
2018
Q2
$172K Sell
3,264
-663
-17% -$35.3K 0.29% 221
2018
Q1
$196K Buy
3,927
+1,333
+51% +$67.2K 0.25% 35
2017
Q4
$124K Buy
+2,594
New +$123K 0.09% 276

Other funds holding SNV

Cerebellum's SNV Position: Q3 2020 in Review

Cerebellum sold out of Synovus (SNV) in Q3 2020, closing a stake of 2,594 shares — an estimated $124K sold.

Cerebellum first reported a position in SNV in Q4 2017 and held it in 8 quarters. The position peaked at $535K in Q4 2019. 301 funds tracked by Wall St. Rank hold SNV as of Q3 2020.

  • Cerebellum reported no remaining Synovus position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 2,594 Synovus shares in Q3 2020, an estimated $124K.
  • Cerebellum first reported a position in Synovus in Q4 2017 and held it in 8 quarters.
  • Cerebellum's Synovus position peaked at $535K in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Synovus as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.